Letter: Altered digoxin bioavalability.
作者信息
Michalopoulos C D, Koutoulidis C V
出版信息
Lancet. 1974 Feb 2;1(7849):167-8. doi: 10.1016/s0140-6736(74)92459-3.
PMID:4129736
Abstract
摘要
相似文献
1
Letter: Altered digoxin bioavalability.信件：地高辛生物利用度改变。
Lancet. 1974 Feb 2;1(7849):167-8. doi: 10.1016/s0140-6736(74)92459-3.
2
The bioavailability of digoxin.
Lancet. 1972 Aug 12;2(7772):311-2.
3
Altered absorption of digoxin in patients given propantheline and metoclopramide.接受丙胺太林和甲氧氯普胺治疗的患者地高辛吸收发生改变。
Lancet. 1973 Feb 24;1(7800):398-400. doi: 10.1016/s0140-6736(73)90252-3.
4
Variation in the biological availability of digoxin.
Lancet. 1972 Aug 12;2(7772):303-7. doi: 10.1016/s0140-6736(72)92908-x.
5
Bioavailability of digoxin: what the clinician needs to know.
Conn Med. 1974 May;38(5):230-2.
6
Dissimilarities of digoxin.
N Engl J Med. 1971 Dec 9;285(24):1376-7. doi: 10.1056/NEJM197112092852414.
7
Editorial: Bioavailability of drugs: focus on digoxin.社论：药物的生物利用度：聚焦地高辛。
Circulation. 1974 Mar;49(3):391-4. doi: 10.1161/01.cir.49.3.391.
8
[Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
Klin Wochenschr. 1975 May 1;53(9):425-9. doi: 10.1007/BF01493367.
9
Non-equivalence of digoxin tablets.
Ann Clin Res. 1974;6(0):suppl 11:4-8.
10
Variation in biologic availability of digoxin from four preparations.四种制剂中地高辛生物利用度的差异。
N Engl J Med. 1971 Dec 9;285(24):1344-7. doi: 10.1056/NEJM197112092852403.
引用本文的文献
1
Bioavailability of drugs: the digoxin dilemma.药物的生物利用度：地高辛的困境。
Clin Pharmacokinet. 1976;1(1):36-51. doi: 10.2165/00003088-197601010-00004.
Zotero 插件